Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT
European Journal of Radiology · 2025
DOI: 10.1016/j.ejrad.2025.112013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Radiology, 2025. Verfasst von Marialena Tsarouchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein 10, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiolo…. Hauptthemen laut MEDLINE: Breast Neoplasms, Contrast Media, Magnetic Resonance Imaging, Mammography. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw, Dutch Research Council.
Abstract (Originalsprache)
Pretherapeutic breast cancer staging is pivotal for patient-centered disease management, guiding treatment stratification and assessing prognostic outcomes. Breast imaging plays a key role in both anatomic and prognostic staging by providing comprehensive insights into disease extent, localization, and tumor aggressiveness characteristics. To date, clinical image-based staging relies on conventional modalities such as digital mammography (DM), digital breast tomosynthesis (DBT), and ultrasound. Considering the phenotypic disparities of breast cancer and their relation to treatment response, other imaging techniques based on contrast-enhanced mechanisms, which highlight areas of increased neovascularity, appear indispensable in breast cancer staging. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) offers a comprehensive 3-dimensional assessment of extent of disease and characterization of lesions, capturing both morphological and functional aspects which are crucial for treatment and monitoring of the disease. Based on this established approach, contrast-enhanced x-ray-based techniques, with high spatial resolution, such as contrast-enhanced mammography (CEM) and dedicated contrast-enhanced breast computed tomography (dCEBCT), have emerged. This review outlines the current status, limitations, and ongoing challenges associated with each one contrast-enhanced imaging modality, while emphasis is given to key breast cancer manifestations and the optimal interpretation of their imaging phenotypes, in the current era of image-based (anatomic and prognostic) breast cancer staging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein 10, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiology, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Plesmanl…
- Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy.
- Department of Radiology, Columbia University Irving Medical Center 161 Fort Washington Avenue, New York, NY 10032, The United States.
- Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein 10, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
Förderung
- ZonMw
- Dutch Research Council
Zitieren
APA
Tsarouchi, M., Hoxhaj, A., Portaluri, A., Sung, J., Sechopoulos, I., Pinker-Domenig, K., & Mann, R. M. (2025). Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112013
Vancouver
Tsarouchi M, Hoxhaj A, Portaluri A, Sung J, Sechopoulos I, Pinker-Domenig K, et al. Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT. European Journal of Radiology. 2025. doi:10.1016/j.ejrad.2025.112013
BibTeX
@article{Tsarouchi2025,
author = {Tsarouchi, Marialena and Hoxhaj, Alma and Portaluri, Antonio and Sung, Janice and Sechopoulos, Ioannis and Pinker-Domenig, Katja and Mann, Ritse M},
title = {Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT},
journal = {European Journal of Radiology},
year = {2025},
doi = {10.1016/j.ejrad.2025.112013}
}
EUVIMED